Literature DB >> 5002800

Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin.

C F Speirs, D Stenhouse, K W Stephen, E T Wallace.   

Abstract

1. A study has been made of serum, mixed and parotid salivary levels attained in normal volunteers following oral dosage of 500 mg phenoxymethylpenicillin tablets, 500 mg crushed phenoxymethylpenicillin tablets in capsules, 500 mg ampicillin, 500 mg cloxacillin and 500 mg cephalexin.2. High mixed saliva levels were obtained with phenoxymethylpenicillin tablets and it is considered that these were due to rapid intra-oral dissolution of surface powder from friable tablets. No saliva levels were detected when tablets from the same batch were put into capsules.3. Low or no saliva levels were achieved with ampicillin, cloxacillin and cephalexin.4. The mode of action of antibiotics in oral infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5002800      PMCID: PMC1665947          DOI: 10.1111/j.1476-5381.1971.tb07173.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  [ON THE SALIVARY ELIMINATION OF SEVERAL ANTIBIOTICS].

Authors:  J PELLERAT
Journal:  Presse Med       Date:  1963-10-26       Impact factor: 1.228

2.  TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION.

Authors:  J R MAY; D M DELVES
Journal:  Lancet       Date:  1965-05-01       Impact factor: 79.321

3.  Parotid fluid flow rate as related to whole saliva volume.

Authors:  I L SHANNON
Journal:  Arch Oral Biol       Date:  1962 May-Jun       Impact factor: 2.633

4.  Acute suppurative parotitis: a study of 161 cases.

Authors:  W W KRIPPAEHNE; T K HUNT; J E DUNPHY
Journal:  Ann Surg       Date:  1962-08       Impact factor: 12.969

5.  Studies on excretion of antibiotics in human saliva. III. Aureomycin.

Authors:  I B BENDER; R S PRESSMAN; S G TASHMAN
Journal:  J Dent Res       Date:  1953-06       Impact factor: 6.116

6.  Studies on excretion of antibiotics in human saliva. II. Chloramphenicol.

Authors:  I B BENDER; R S PRESSMAN; S G TASHMAN
Journal:  J Dent Res       Date:  1953-04       Impact factor: 6.116

7.  Studies on excretion of antibiotics in human saliva. I. Penicillin and streptomycin.

Authors:  I B BENDER; R S PRESSMAN; S G TASHMAN
Journal:  J Am Dent Assoc       Date:  1953-02       Impact factor: 3.634

8.  Ampicillin levels in sputum, serum, and saliva.

Authors:  S M Stewart; M Fisher; J E Young; W Lutz
Journal:  Thorax       Date:  1970-05       Impact factor: 9.139

9.  Antibacterial drugs for oral infections.

Authors:  C F Speirs; K W Stephen
Journal:  Br Dent J       Date:  1968-08-20       Impact factor: 1.626

10.  Recording the pattern of salivary flow.

Authors:  D K Mason; R M Harden; D Rowan; W D Alexander
Journal:  J Dent Res       Date:  1966 Sep-Oct       Impact factor: 6.116

  10 in total
  9 in total

1.  Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology.

Authors:  K W Stephen; C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 2.  Oral absorption and secretion of drugs.

Authors:  C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 3.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  [Biochemical aspects of human salivary gland secretions].

Authors:  M Münzel
Journal:  Arch Otorhinolaryngol       Date:  1976

5.  Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.

Authors:  J W Paxton; F Rowell; J G Ratcliffe; D G Lambie; R Nanda; I D Melville; R H Johnson
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

6.  Factors determining the passage of drugs from blood into saliva.

Authors:  K W Stephen; J McCrossan; D Mackenzie; C B Macfarlane; C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

Review 7.  The aminopenicillins: development and comparative properties.

Authors:  D S Reeves; D W Bullock
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 8.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

9.  Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.

Authors:  P Workman; C R Wiltshire; P N Plowman; N M Bleehen
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.